Concentrix Corp Files 8-K: Bylaws Amended, Financials Included
Ticker: CNXC · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1803599
Sentiment: neutral
Topics: corporate-governance, financial-reporting, filing
TL;DR
CNXC filed an 8-K on Jan 9th, amending bylaws and including financials. Delaware corp, fiscal year end Nov 30.
AI Summary
Concentrix Corporation filed an 8-K on January 10, 2025, reporting events as of January 9, 2025. The filing indicates amendments to articles of incorporation or bylaws and includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on November 30.
Why It Matters
This 8-K filing signals potential changes in Concentrix Corporation's governance or operational structure and provides updated financial information for investors.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any immediate negative news or significant risk factors.
Key Numbers
- 001-39494 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-1605762 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Concentrix Corporation (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- November 30 (date) — Fiscal Year End
- January 9, 2025 (date) — Date of Earliest Event Reported
- January 10, 2025 (date) — Filing Date
FAQ
What specific amendments were made to Concentrix Corporation's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the purpose of filing financial statements and exhibits with this 8-K?
The filing explicitly states that financial statements and exhibits are included as part of this 8-K report.
When is Concentrix Corporation's fiscal year end?
Concentrix Corporation's fiscal year ends on November 30.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported in this 8-K filing is January 9, 2025.
In which U.S. state is Concentrix Corporation incorporated?
Concentrix Corporation is incorporated in Delaware.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-10 16:13:09
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market
Filing Documents
- cnxc-20250109.htm (8-K) — 27KB
- exhibit32-amendmentno2toth.htm (EX-3.2) — 6KB
- 0001803599-25-000005.txt ( ) — 162KB
- cnxc-20250109.xsd (EX-101.SCH) — 2KB
- cnxc-20250109_lab.xml (EX-101.LAB) — 23KB
- cnxc-20250109_pre.xml (EX-101.PRE) — 13KB
- cnxc-20250109_htm.xml (XML) — 3KB
03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 9, 2025, the Board of Directors of Concentrix Corporation (the "Company") adopted an amendment (the "Amendment") to the Amended and Restated Bylaws, as amended, of the Company (the "Bylaws"), effective immediately. The Amendment amended Article 10 of the Bylaws to change the supermajority provision that required the vote of at least 66-2/3 percent of the voting power of the shares of the capital stock of the Company to adopt, amend, or repeal the Bylaws to a simple majority. The foregoing summary of the Amendment is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Document Description 3.2 Amendment No. 2 to the Amended and Restated Bylaws of Concentrix Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 10, 2025 CONCENTRIX CORPORATION By: /s/ Jane C. Fogarty Jane C. Fogarty Executive Vice President, Legal